Cargando…
Perivascular Neuropilin‐1 expression is an independent marker of improved survival in renal cell carcinoma
Renal cell carcinoma (RCC) treatment has improved in the last decade with the introduction of drugs targeting tumor angiogenesis. However, the 5‐year survival of metastatic disease is still only 10–15%. Here, we explored the prognostic significance of compartment‐specific expression of Neuropilin 1...
Autores principales: | Morin, Eric, Lindskog, Cecilia, Johansson, Martin, Egevad, Lars, Sandström, Per, Harmenberg, Ulrika, Claesson‐Welsh, Lena, Sjöberg, Elin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155095/ https://www.ncbi.nlm.nih.gov/pubmed/31880322 http://dx.doi.org/10.1002/path.5380 |
Ejemplares similares
-
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
por: Frödin, Magnus, et al.
Publicado: (2017) -
A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis
por: Sjöberg, Elin, et al.
Publicado: (2018) -
VEGF receptor‐2/neuropilin 1 trans‐complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival
por: Morin, Eric, et al.
Publicado: (2018) -
Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study
por: Almdalal, Tarik, et al.
Publicado: (2022) -
Volumetric FDG-PET predicts overall and progression- free survival after 14 days of targeted therapy in metastatic renal cell carcinoma
por: Farnebo, Jacob, et al.
Publicado: (2014)